1Ogihara T,Asano T,Ando K, et al. Angiotensin Ⅱ-induced insulin resistance is associated with enhanced insulin signaling[J]. Hypertension, 2002,40(6 ) : 872-879.
2Hansson L, Lindholm LH, Niskanen L, et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascalar morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomized trial [ J]. Lancet, 1999, 353(9153) :611-616.
3The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-oonverting enzyme inhibitor or calcium channel blocker vs diuretic:The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ( ALLHAT ) [ J ]. JAMA, 2002,288 ( 23 ) :2981-2997.
4Gerstein HC, Yusuf S, Holman R, et al. Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention:the DREAM trial[J]. Diabetologia,2004,47(9) : 1519-1527.
5Shiuchi T, Cui TX, Wu L, et al. ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO [ J ]. Hypertention,2002,40(3) : 329-334.
6Scheen AJ. Prevention of type 2 diabetes mellitus through inhibition of the Renin- Angiotensin system [J]. Drugs, 2004,64 ( 22 ) : 2537-2565.
7Teo K, Yusuf S, Anderson C, et al. Rationale, design, and baseline characteristics of 2 large, simple randomized trials evaluating telmisartan,ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Remipril Global EndpointTrial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease(ONTARGET/TRANSCEND) trials[J] . Am Heart J,2004,148(1) :52- 61.
8Prisant LM.Preventing type Ⅱ diabetes mellitus[J]. J Clin Pharmacol,2004,44(4) :406-413.
9Forgari R,Zoppi A, Lazzari P, et al. ACE inhibition but not angiotensin Ⅱ antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients[ J]. J Cardiovasc Pharmacol, 1998,32(4) :616-620.
10Folli F, Saad MJ, Velloso L, et al. Crosstalk between the insulin and angiotensin Ⅱ sinalling system[J]. Exp Clin Endocrinol Diabetes,1999,107(2) : 133-139.
